{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:52:20Z","timestamp":1775832740924,"version":"3.50.1"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Science and Technology Development Fund, Macau SAR","award":["005\/2023\/SKL"],"award-info":[{"award-number":["005\/2023\/SKL"]}]},{"name":"The University of Macau","award":["MYRG-GRG2023-00087-ICMS"],"award-info":[{"award-number":["MYRG-GRG2023-00087-ICMS"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>In recent years, there has been a notable increase in the incidence and mortality rates of prostate cancer (PCa) in China, highlighting it as a significant public health issue. This study aimed to investigate the genetic association of PCa in China to better inform national disease management and medical resource allocation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A systematic literature review was conducted using 5 English databases (Web of Science, PubMed, Embase, Cochrane, Scopus) and 1 Chinese database (CNKI) to identify articles published from database inception to October 8, 2022, which reported the genetic associations of PCa in China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 11,195 articles retrieved, 41 were included in the review. A total of 116 different polymorphisms (including single nucleotide polymorphisms, deletions, insertions, and repeat lengths) in 58 genes were studied in Chinese populations. Among these, 37 out of 51 polymorphisms in 28 candidate genes such as BIRC5, C2orf43, COX-2, CYR61 (IGFBP10), DNMT1, DNMT3B, EXO1, FOXP4, and 7 unmapped SNPs were found to have either a positive or negative effect on PCa risk. However, 18 variants in 5 genes remain controversial across different studies. Additionally, 23 SNPs in 16 genes were reported to be associated with disease stage, Gleason score, PSA levels, PCa risk, and clinicopathological characteristics of PCa in China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In Chinese populations, PCa risk and clinical features may result from individual genes, gene-gene interactions, and gene-environment interactions. These findings provide important insights into the relationship between genetic susceptibility and PCa risk in Chinese men.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12885-025-13830-9","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T08:44:48Z","timestamp":1743756288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic associations of prostate cancer in China: a systematic review"],"prefix":"10.1186","volume":"25","author":[{"given":"Yimin","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina Oi Lam","family":"Ung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"issue":"3","key":"13830_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"13830_CR2","doi-asserted-by":"publisher","first-page":"102068","DOI":"10.1016\/j.canep.2021.102068","volume":"76","author":"Z Shi","year":"2022","unstructured":"Shi Z, Lin J, Wu Y, Fu S, Wan Y, Fang Y. Burden of cancer and changing cancer spectrum among older adults in China: Trends and projections to 2030. Cancer Epidemiol. 2022;76:102068. https:\/\/doi.org\/10.1016\/j.canep.2021.102068.","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"13830_CR3","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol. 2021;4(6):877\u201392. https:\/\/doi.org\/10.1016\/j.euo.2021.09.006.","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"13830_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer\u2013analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78\u201385. https:\/\/doi.org\/10.1056\/NEJM200007133430201.","journal-title":"N Engl J Med"},{"issue":"1","key":"13830_CR5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-5347(01)62086-X","volume":"161","author":"LS Cook","year":"1999","unstructured":"Cook LS, Goldoft M, Schwartz SM, Weiss NS. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol. 1999;161(1):152\u20135.","journal-title":"J Urol"},{"issue":"1","key":"13830_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ijc.33808","volume":"150","author":"D Liu","year":"2022","unstructured":"Liu D, Zhu J, Zhou D, et al. A transcriptome-wide association study identifies novel candidate susceptibility genes for prostate cancer risk. Int J Cancer. 2022;150(1):80\u201390. https:\/\/doi.org\/10.1002\/ijc.33808.","journal-title":"Int J Cancer"},{"issue":"2","key":"13830_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/pros.21235","volume":"71","author":"H Liu","year":"2011","unstructured":"Liu H, Wang B, Han C. Meta-analysis of genome-wide and replication association studies on prostate cancer. Prostate. 2011;71(2):209\u201324. https:\/\/doi.org\/10.1002\/pros.21235.","journal-title":"Prostate"},{"issue":"7","key":"13830_CR8","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci [published correction appears in Nat Genet. 2019 Feb;51(2):363. doi: 10.1038\/s41588-018-0330-6]. Nat Genet. 2018;50(7):928\u201336. https:\/\/doi.org\/10.1038\/s41588-018-0142-8.","journal-title":"Nat Genet"},{"issue":"8","key":"13830_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1046","volume":"27","author":"S Benafif","year":"2018","unstructured":"Benafif S, Kote-Jarai Z, Eeles RA, PRACTICAL Consortium. A review of prostate cancer genome-wide association studies (GWAS). Cancer Epidemiol Biomarkers Prev. 2018;27(8):845\u201357. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-1046.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13830_CR10","doi-asserted-by":"publisher","unstructured":"Conti DV, Darst BF, Moss LC, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction [published correction appears in Nat Genet. 2021 Mar;53(3):413. https:\/\/doi.org\/10.1038\/s41588-021-00786-2]. Nat Genet. 2021;53(1):65\u201375. https:\/\/doi.org\/10.1038\/s41588-020-00748-0.","DOI":"10.1038\/s41588-021-00786-2 10.1038\/s41588-020-00748-0"},{"issue":"11","key":"13830_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ng.2424","volume":"44","author":"J Xu","year":"2012","unstructured":"Xu J, Mo Z, Ye D, et al. Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet. 2012;44(11):1231\u20135. https:\/\/doi.org\/10.1038\/ng.2424.","journal-title":"Nat Genet"},{"issue":"5","key":"13830_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","volume":"18","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Mo M, Wei Y, et al. Epidemiology and genomics of prostate cancer in Asian men. Nat Rev Urol. 2021;18(5):282\u2013301. https:\/\/doi.org\/10.1038\/s41585-021-00442-8.","journal-title":"Nat Rev Urol"},{"key":"13830_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71. Published 2021 Mar 29.","journal-title":"BMJ."},{"issue":"9","key":"13830_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135. https:\/\/doi.org\/10.1007\/s10654-010-9491-z.","journal-title":"Eur J Epidemiol"},{"key":"13830_CR15","doi-asserted-by":"publisher","unstructured":"Huang WJ, Wu LJ, Min ZC, et al. Interleukin-6 -572G\/C polymorphism and prostate cancer susceptibility. Genet Mol Res. 2016;15(3):https:\/\/doi.org\/10.4238\/gmr.15037563. Published 2016 Sep 16. https:\/\/doi.org\/10.4238\/gmr.15037563.","DOI":"10.4238\/gmr.15037563 10.4238\/gmr.15037563"},{"issue":"36","key":"13830_CR16","doi-asserted-by":"publisher","first-page":"e21790","DOI":"10.1097\/MD.0000000000021790","volume":"99","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zheng W, Li C. Association of long-chain non-coding RNA GAS5 gene polymorphisms with prostate cancer risk and prognosis in Chinese Han population. Medicine (Baltimore). 2020;99(36):e21790. https:\/\/doi.org\/10.1097\/MD.0000000000021790.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"13830_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1590\/S1677-5538.IBJU.2017.0146","volume":"44","author":"D Cao","year":"2018","unstructured":"Cao D, Gu C, Ye D, Dai B, Zhu Y. PCA3 rs544190G>A and prostate cancer risk in an eastern Chinese population. Int Braz J Urol. 2018;44(3):500\u20135. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2017.0146.","journal-title":"Int Braz J Urol"},{"key":"13830_CR18","first-page":"1990","volume":"12","author":"Y Luo","year":"2018","unstructured":"Luo Y, Li K, Guan R, Shen J, Liu X, Li H. Correlation between SRD5A2 gene polymorphisms and prostate cancer in the population of Yi nationality in Yunnan Province. J Pract Med. 2018;12:1990\u20134.","journal-title":"J Pract Med"},{"key":"13830_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/OTT.S91420","volume":"9","author":"J Chen","year":"2016","unstructured":"Chen J, Ying XM, Huang XM, Huang P, Yan SC. Association between polymorphisms in selected inflammatory response genes and the risk of prostate cancer. Onco Targets Ther. 2016;9:223\u20139. https:\/\/doi.org\/10.2147\/OTT.S91420. Published 2016 Jan 11.","journal-title":"Onco Targets Ther"},{"key":"13830_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/1471-2407-13-356","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Cui X, Zhou H, et al. Functional promoter -31G\/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case-control study. BMC Cancer. 2013;13:356. https:\/\/doi.org\/10.1186\/1471-2407-13-356. Published 2013 Jul 24.","journal-title":"BMC Cancer"},{"key":"13830_CR21","doi-asserted-by":"publisher","first-page":"674039","DOI":"10.1155\/2015\/674039","volume":"2015","author":"X Cui","year":"2015","unstructured":"Cui X, Yan H, Ou TW, Jia CS, Wang Q, Xu JJ. Genetic variations in inflammatory response genes and their association with the risk of prostate cancer. Biomed Res Int. 2015;2015:674039. https:\/\/doi.org\/10.1155\/2015\/674039.","journal-title":"Biomed Res Int"},{"key":"13830_CR22","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.12659\/MSM.893471","volume":"21","author":"X Han","year":"2015","unstructured":"Han X, Zhang JJ, Yao N, et al. Polymorphisms in NFKB1 and NFKBIA genes modulate the risk of developing prostate cancer among Han Chinese. Med Sci Monit. 2015;21:1707\u201315. https:\/\/doi.org\/10.12659\/MSM.893471. Published 2015 Jun 12.","journal-title":"Med Sci Monit"},{"key":"13830_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.13263\/j.cnki.nja.2019.08.004","volume":"8","author":"C Zhao","year":"2019","unstructured":"Zhao C, Xu H, Xu B. The rs4705342 gene mutation in the promoter region of the miR-143\/145 cluster associated with the risk of prostate cancer in the Chinese Han population. Natl J Androl. 2019;8:696\u2013702. https:\/\/doi.org\/10.13263\/j.cnki.nja.2019.08.004.","journal-title":"Natl J Androl"},{"issue":"10","key":"13830_CR24","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.7314\/apjcp.2012.13.10.5241","volume":"13","author":"YF Zhou","year":"2012","unstructured":"Zhou YF, Zhang GB, Qu P, Zhou J, Pan HX, Hou JQ. Association between single nucleotide polymorphisms in the XRCC1 gene and susceptibility to prostate cancer in Chinese men. Asian Pac J Cancer Prev. 2012;13(10):5241\u20133. https:\/\/doi.org\/10.7314\/apjcp.2012.13.10.5241.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"13830_CR25","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.7314\/apjcp.2014.15.7.3129","volume":"15","author":"LL Zhang","year":"2014","unstructured":"Zhang LL, Sun L, Zhu XQ, et al. rs10505474 and rs7837328 at 8q24 cumulatively confer risk of prostate cancer in Northern Han Chinese. Asian Pac J Cancer Prev. 2014;15(7):3129\u201332. https:\/\/doi.org\/10.7314\/apjcp.2014.15.7.3129.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"13830_CR26","first-page":"1077","volume":"20","author":"BS He","year":"2014","unstructured":"He BS, Pan YQ, Zhu CB. Zhonghua Nan Ke Xue. 2014;20(12):1077\u201381.","journal-title":"Zhonghua Nan Ke Xue"},{"issue":"5","key":"13830_CR27","first-page":"1223","volume":"20","author":"XH Li","year":"2015","unstructured":"Li XH, Xu Y, Yang K, et al. Association of THADA, FOXP4, GPRC6A\/RFX6 genes, and 8q24 risk alleles with prostate cancer in Northern Chinese men. J BUON. 2015;20(5):1223\u20138.","journal-title":"J BUON"},{"issue":"12","key":"13830_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/pros.23387","volume":"77","author":"X Lin","year":"2017","unstructured":"Lin X, Chen Z, Gao P, et al. TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese. Prostate. 2017;77(12):1271\u20138. https:\/\/doi.org\/10.1002\/pros.23387.","journal-title":"Prostate"},{"issue":"7","key":"13830_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3760\/cma.j.issn.0529-5807.2016.07.005","volume":"45","author":"M Liu","year":"2016","unstructured":"Liu M, Miao N, Zhu Y, et al. Zhonghua Bing Li Xue Za Zhi. 2016;45(7):451\u20136. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5807.2016.07.005.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"15","key":"13830_CR30","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/pros.21207","volume":"70","author":"I Agalliu","year":"2010","unstructured":"Agalliu I, Leanza SM, Smith L, et al. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population. Prostate. 2010;70(15):1716\u201327. https:\/\/doi.org\/10.1002\/pros.21207.","journal-title":"Prostate"},{"issue":"37","key":"13830_CR31","doi-asserted-by":"publisher","first-page":"61305","DOI":"10.18632\/oncotarget.18064","volume":"8","author":"T Liu","year":"2017","unstructured":"Liu T, Gulinaer A, Shi X, et al. Gene polymorphisms in the PI3K\/AKT\/mTOR signaling pathway contribute to prostate cancer susceptibility in Chinese men. Oncotarget. 2017;8(37):61305\u201317. https:\/\/doi.org\/10.18632\/oncotarget.18064. Published 2017 May 22.","journal-title":"Oncotarget"},{"key":"13830_CR32","doi-asserted-by":"publisher","first-page":"36264","DOI":"10.1038\/srep36264","volume":"6","author":"YY Qu","year":"2016","unstructured":"Qu YY, Zhou SX, Zhang X, et al. Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: results from an ethnic Han Chinese population. Sci Rep. 2016;6:36264. https:\/\/doi.org\/10.1038\/srep36264. Published 2016 Nov 3.","journal-title":"Sci Rep"},{"key":"13830_CR33","doi-asserted-by":"publisher","first-page":"956","DOI":"10.13464\/j.scuxbyxb.2014.06.016","volume":"6","author":"H Liao","year":"2014","unstructured":"Liao H, Zhang L, Chen P, et al. Insertion\/deletion polymorphism of IL1A 3\u2019-UTR associated with the susceptibility of prostate cancer. J Sichuan Univ (Med Sci Ed). 2014;6:956\u20139. https:\/\/doi.org\/10.13464\/j.scuxbyxb.2014.06.016.","journal-title":"J Sichuan Univ (Med Sci Ed)"},{"issue":"4","key":"13830_CR34","doi-asserted-by":"publisher","first-page":"415","DOI":"10.18926\/AMO\/62379","volume":"75","author":"J Sun","year":"2021","unstructured":"Sun J, Lin W, Wang Q, et al. The cell cycle checkpoint gene, RAD17 rs1045051, is associated with prostate cancer risk. Acta Med Okayama. 2021;75(4):415\u201321. https:\/\/doi.org\/10.18926\/AMO\/62379.","journal-title":"Acta Med Okayama"},{"issue":"1","key":"13830_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/pcan.2012.41","volume":"16","author":"L Tao","year":"2013","unstructured":"Tao L, Chen J, Zhou H, et al. A functional polymorphism in the CYR61 (IGFBP10) gene is associated with prostate cancer risk. Prostate Cancer Prostatic Dis. 2013;16(1):95\u2013100. https:\/\/doi.org\/10.1038\/pcan.2012.41.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"13830_CR36","first-page":"886","volume":"4","author":"X Mao","year":"2014","unstructured":"Mao X, Li J, Xu X, et al. Involvement of different mechanisms for the association of CAG repeat length polymorphism in androgen receptor gene with prostate cancer. Am J Cancer Res. 2014;4(6):886\u201396 Published 2014 Nov 19.","journal-title":"Am J Cancer Res"},{"issue":"15","key":"13830_CR37","doi-asserted-by":"publisher","first-page":"24362","DOI":"10.18632\/oncotarget.13848","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M, Li Q, Gu C, et al. Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations. Oncotarget. 2017;8(15):24362\u201371. https:\/\/doi.org\/10.18632\/oncotarget.13848.","journal-title":"Oncotarget"},{"issue":"1","key":"13830_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3233\/CBM-150536","volume":"16","author":"X Li","year":"2016","unstructured":"Li X, Gao Y, Zhou H, et al. The relationship between functional promoter -94 ins\/del ATTG polymorphism in NF-\u03ba B1 gene and the risk of urinary cancer. Cancer Biomark. 2016;16(1):11\u20137. https:\/\/doi.org\/10.3233\/CBM-150536.","journal-title":"Cancer Biomark"},{"issue":"2","key":"13830_CR39","doi-asserted-by":"publisher","first-page":"176","DOI":"10.22037\/uj.v16i7.5585","volume":"18","author":"B Xu","year":"2020","unstructured":"Xu B, Zhang M, Liu C, et al. Association of long non-coding RNA MEG3 polymorphisms and risk of prostate cancer in Chinese Han population. Urol J. 2020;18(2):176\u201380. https:\/\/doi.org\/10.22037\/uj.v16i7.5585. Published 2020 Aug 22.","journal-title":"Urol J"},{"key":"13830_CR40","doi-asserted-by":"publisher","first-page":"36290","DOI":"10.1038\/srep36290","volume":"6","author":"JL Wu","year":"2016","unstructured":"Wu JL, Zhou SX, Zhao R, et al. MTHFR c.677C>T inhibits cell proliferation and decreases prostate cancer susceptibility in the Han Chinese population in Shanghai. Sci Rep. 2016;6:36290. https:\/\/doi.org\/10.1038\/srep36290. Published 2016 Nov 7.","journal-title":"Sci Rep"},{"issue":"5","key":"13830_CR41","doi-asserted-by":"publisher","first-page":"e37866","DOI":"10.1371\/journal.pone.0037866","volume":"7","author":"QZ Long","year":"2012","unstructured":"Long QZ, Du YF, Ding XY, et al. Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A, and RFX6 genes with prostate cancer in the Chinese population. PLoS One. 2012;7(5):e37866. https:\/\/doi.org\/10.1371\/journal.pone.0037866.","journal-title":"PLoS One"},{"issue":"2","key":"13830_CR42","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/carcin\/bgr279","volume":"33","author":"M Wang","year":"2012","unstructured":"Wang M, Liu F, Hsing AW, et al. Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium. Carcinogenesis. 2012;33(2):356\u201360. https:\/\/doi.org\/10.1093\/carcin\/bgr279.","journal-title":"Carcinogenesis"},{"issue":"2","key":"13830_CR43","first-page":"2074","volume":"9","author":"G Li","year":"2016","unstructured":"Li G, Qiao Q, Wang L, Wang X, Liu L, Zheng Y. Association of estrogen receptor alpha gene polymorphisms with the risk, therapeutic outcome, and prognosis of ADT-resistant prostate cancer in Chinese Han population. Int J Clin Exp Pathol. 2016;9(2):2074\u201382.","journal-title":"Int J Clin Exp Pathol"},{"key":"13830_CR44","doi-asserted-by":"publisher","first-page":"8553530","DOI":"10.1155\/2022\/8553530","volume":"2022","author":"HJ Zhang","year":"2022","unstructured":"Zhang HJ, Liu Z, Kan L. Prostate cancer susceptibility loci identified in GATA2 and ZMIZ1 in Chinese population. Int J Genomics. 2022;2022:8553530. https:\/\/doi.org\/10.1155\/2022\/8553530. Published 2022 Mar 24.","journal-title":"Int J Genomics"},{"key":"13830_CR45","doi-asserted-by":"publisher","first-page":"665","DOI":"10.19401\/j.cnki.1007-3639.2018.09.004","volume":"9","author":"C Gu","year":"2018","unstructured":"Gu C, Wu J, Zhu Y, Xu H, Qin X, Zhu Y, Ye D. Genetic variations of the ADIPOQ gene and risk of prostate cancer. China Oncol. 2018;9:665\u201370. https:\/\/doi.org\/10.19401\/j.cnki.1007-3639.2018.09.004.","journal-title":"China Oncol"},{"issue":"5","key":"13830_CR46","doi-asserted-by":"publisher","first-page":"923","DOI":"10.7150\/jca.22802","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Chen H, Jiang G, et al. Genome-wide association study (GWAS) of germline copy number variations (CNVs) reveal genetic risks of prostate cancer in Chinese population. J Cancer. 2018;9(5):923\u20138. https:\/\/doi.org\/10.7150\/jca.22802. Published 2018 Feb 27.","journal-title":"J Cancer"},{"issue":"5","key":"13830_CR47","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1007\/s13277-015-4298-x","volume":"37","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li P, Xu A, et al. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people. Tumour Biol. 2016;37(5):6653\u20139. https:\/\/doi.org\/10.1007\/s13277-015-4298-x.","journal-title":"Tumour Biol"},{"issue":"52","key":"13830_CR48","doi-asserted-by":"publisher","first-page":"e18523","DOI":"10.1097\/MD.0000000000018523","volume":"98","author":"M Zhang","year":"2019","unstructured":"Zhang M, Wang Y, Wang C, et al. Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population: a case-control study. Medicine (Baltimore). 2019;98(52):e18523. https:\/\/doi.org\/10.1097\/MD.0000000000018523.","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"13830_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/mc.22130","volume":"54","author":"Q Li","year":"2015","unstructured":"Li Q, Gu C, Zhu Y, et al. Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population. Mol Carcinog. 2015;54(8):632\u201341. https:\/\/doi.org\/10.1002\/mc.22130.","journal-title":"Mol Carcinog"},{"key":"13830_CR50","doi-asserted-by":"publisher","unstructured":"Li Q, Gu C, Zhu Y, et al. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population [published correction appears in PLoS One. 2014;9(1). https:\/\/doi.org\/10.1371\/annotation\/bc36c048-60e4-48a2-908d-6253e93df062]. PLoS One. 2013;8(8):e71968. Published 2013 Aug 5. https:\/\/doi.org\/10.1371\/journal.pone.0071968.","DOI":"10.1371\/annotation\/bc36c048-60e4-48a2-908d-6253e93df062 10.1371\/journal.pone.0071968"},{"issue":"11","key":"13830_CR51","doi-asserted-by":"publisher","first-page":"e78254","DOI":"10.1371\/journal.pone.0078254","volume":"8","author":"Y Chen","year":"2013","unstructured":"Chen Y, Xin X, Li J, et al. RTK\/ERK pathway under natural selection associated with prostate cancer. PLoS One. 2013;8(11):e78254. https:\/\/doi.org\/10.1371\/journal.pone.0078254. Published 2013 Nov 4.","journal-title":"PLoS One"},{"key":"13830_CR52","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.13263\/j.cnki.nja.2012.12.005","volume":"12","author":"Y Cui","year":"2012","unstructured":"Cui Y, Shi Y, Shen H, Fan Y, Cao W, Xie J, Shao Q. Susceptibility to prostate cancer in Han Chinese: single nucleotide polymorphism analysis of 1,667 cases. Natl J Androl. 2012;12:1069\u201374. https:\/\/doi.org\/10.13263\/j.cnki.nja.2012.12.005.","journal-title":"Natl J Androl"},{"issue":"15","key":"13830_CR53","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/pros.22629","volume":"73","author":"R Na","year":"2013","unstructured":"Na R, Liu F, Zhang P, et al. Evaluation of reported prostate cancer risk-associated SNPs from genome-wide association studies of various racial populations in Chinese men. Prostate. 2013;73(15):1623\u201335. https:\/\/doi.org\/10.1002\/pros.22629.","journal-title":"Prostate"},{"key":"13830_CR54","doi-asserted-by":"crossref","unstructured":"Dong L, Xu W, Woon D, et al. Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada. Eur Urol Open Sci. 2020;19:e1700.","DOI":"10.1016\/S2666-1683(20)33739-3"},{"issue":"Suppl 1","key":"13830_CR55","doi-asserted-by":"publisher","first-page":"E104","DOI":"10.1002\/mc.21870","volume":"51","author":"MR Safarinejad","year":"2012","unstructured":"Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men. Mol Carcinog. 2012;51(Suppl 1):E104\u201317. https:\/\/doi.org\/10.1002\/mc.21870.","journal-title":"Mol Carcinog"},{"key":"13830_CR56","doi-asserted-by":"publisher","unstructured":"Li X, Zhu C, Tu WH, Yang N, Qin H, Sun Z. ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract. PLoS One. 2011;6(9). https:\/\/doi.org\/10.1371\/journal.pone.0025040.","DOI":"10.1371\/journal.pone.0025040"},{"issue":"1","key":"13830_CR57","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1038\/s41467-019-12267-6","volume":"10","author":"R Takata","year":"2019","unstructured":"Takata R, Takahashi A, Fujita M, et al. 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. Nat Commun. 2019;10(1):4422. https:\/\/doi.org\/10.1038\/s41467-019-12267-6. Published 2019 Sep 27.","journal-title":"Nat Commun"},{"issue":"11","key":"13830_CR58","first-page":"1279","volume":"11","author":"CH van Gils","year":"2002","unstructured":"van Gils CH, Bostick RM, Stern MC, Taylor JA. Differences in base excision repair capacity may modulate the effect of dietary antioxidant intake on prostate cancer risk: an example of polymorphisms in the XRCC1 gene. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1279\u201384.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13830_CR59","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.200709057","volume":"180","author":"F Yang","year":"2008","unstructured":"Yang F, Eckardt S, Leu NA, McLaughlin KJ, Wang PJ. Mouse TEX15 is essential for DNA double-strand break repair and chromosomal synapsis during male meiosis. J Cell Biol. 2008;180:673\u20139.","journal-title":"J Cell Biol"},{"issue":"1","key":"13830_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1055-9965.epi-03-0053","volume":"13","author":"BA Rybicki","year":"2004","unstructured":"Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS. DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(1):23\u20139. https:\/\/doi.org\/10.1158\/1055-9965.epi-03-0053.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"13830_CR61","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.eururo.2007.04.008","volume":"52","author":"O Cussenot","year":"2007","unstructured":"Cussenot O, Azzouzi AR, Nicolaiew N, et al. Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors. Eur Urol. 2007;52(4):1082\u20137. https:\/\/doi.org\/10.1016\/j.eururo.2007.04.008.","journal-title":"Eur Urol"},{"issue":"4","key":"13830_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.eururo.2005.06.011","volume":"48","author":"YL Giwercman","year":"2005","unstructured":"Giwercman YL, Abrahamsson PA, Giwercman A, Gadaleanu V, Ahlgren G. The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population. Eur Urol. 2005;48(4):679\u201385. https:\/\/doi.org\/10.1016\/j.eururo.2005.06.011.","journal-title":"Eur Urol"},{"issue":"5","key":"13830_CR63","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/1097-0142(20010901)92:5<1130::aid-cncr1430>3.0.co;2-b","volume":"92","author":"AG Latil","year":"2001","unstructured":"Latil AG, Azzouzi R, Cancel GS, et al. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer. 2001;92(5):1130\u20137. https:\/\/doi.org\/10.1002\/1097-0142(20010901)92:5<1130::aid-cncr1430>3.0.co;2-b.","journal-title":"Cancer"},{"issue":"10","key":"13830_CR64","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1054\/bjoc.2001.1789","volume":"84","author":"N Mononen","year":"2001","unstructured":"Mononen N, Ikonen T, Syrj\u00e4koski K, et al. A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland. Br J Cancer. 2001;84(10):1344\u20137. https:\/\/doi.org\/10.1054\/bjoc.2001.1789.","journal-title":"Br J Cancer"},{"issue":"4","key":"13830_CR65","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00008571-200206000-00006","volume":"12","author":"T S\u00f6derstr\u00f6m","year":"2002","unstructured":"S\u00f6derstr\u00f6m T, Wadelius M, Andersson SO, et al. 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer. Pharmacogenetics. 2002;12(4):307\u201312. https:\/\/doi.org\/10.1097\/00008571-200206000-00006.","journal-title":"Pharmacogenetics"},{"issue":"3","key":"13830_CR66","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/jcb.20696","volume":"97","author":"JT Dong","year":"2006","unstructured":"Dong JT. Prevalent mutations in prostate cancer. J Cell Biochem. 2006;97(3):433\u201347. https:\/\/doi.org\/10.1002\/jcb.20696.","journal-title":"J Cell Biochem"},{"issue":"7","key":"13830_CR67","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/1061186X.2017.1315686","volume":"25","author":"J Liu","year":"2017","unstructured":"Liu J, Li M, Wang Y, Luo J. Curcumin sensitizes prostate cancer cells to radiation partly via epigenetic activation of miR-143 and miR-143 mediated autophagy inhibition. J Drug Target. 2017;25(7):645\u201352. https:\/\/doi.org\/10.1080\/1061186X.2017.1315686.","journal-title":"J Drug Target"},{"key":"13830_CR68","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/jclinpath-2011-200083","volume":"64","author":"S vren","year":"2011","unstructured":"vren S, Dermen A, Lockwood G, Fleshner N, Sweet J. mTOR-RAPTOR and 14\u20133\u20133\u03c3 immunohistochemical expression in high grade prostatic intraepithelial neoplasia and prostatic adenocarcinomas: a tissue microarray study. J Clin Pathol. 2011;64:683\u20138.","journal-title":"J Clin Pathol"},{"key":"13830_CR69","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3389\/fpls.2018.01236","volume":"9","author":"Q Hu","year":"2018","unstructured":"Hu Q, Zhang C, Xue Z, et al. OsRAD17 is required for meiotic double-strand break repair and plays a redundant role with OsZIP4 in synaptonemal complex assembly. Front Plant Sci. 2018;9:1236. https:\/\/doi.org\/10.3389\/fpls.2018.01236. Published 2018 Aug 29.","journal-title":"Front Plant Sci"},{"issue":"6","key":"13830_CR70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1530\/eje.0.1490469","volume":"149","author":"C Ntais","year":"2003","unstructured":"Ntais C, Polycarpou A, Tsatsoulis A. Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes. Eur J Endocrinol. 2003;149(6):469\u201377. https:\/\/doi.org\/10.1530\/eje.0.1490469.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"13830_CR71","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/s0021-9150(00)00739-5","volume":"157","author":"DJ Gaughan","year":"2001","unstructured":"Gaughan DJ, Kluijtmans LA, Barbaux S, et al. The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations. Atherosclerosis. 2001;157(2):451\u20136. https:\/\/doi.org\/10.1016\/s0021-9150(00)00739-5.","journal-title":"Atherosclerosis"},{"key":"13830_CR72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/cr.2007.115","volume":"18","author":"GM Li","year":"2008","unstructured":"Li GM. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008;18:85\u201398.","journal-title":"Cell Res"},{"key":"13830_CR73","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.4049\/jimmunol.159.11.5192","volume":"159","author":"L Borges","year":"1997","unstructured":"Borges L, Hsu ML, Fanger N, Kubin M, Cosman D. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol. 1997;159:5192\u20136.","journal-title":"J Immunol"},{"issue":"6","key":"13830_CR74","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1084\/jem.188.6.1039","volume":"188","author":"OV Volpert","year":"1998","unstructured":"Volpert OV, Fong T, Koch AE, et al. Inhibition of angiogenesis by interleukin 4. J Exp Med. 1998;188(6):1039\u201346.","journal-title":"J Exp Med"},{"issue":"7","key":"13830_CR75","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ejso.2007.09.008","volume":"34","author":"C Marchal","year":"2008","unstructured":"Marchal C, Redondo M, Reyes-Engel A, et al. Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J Surg Oncol. 2008;34(7):805\u201310. https:\/\/doi.org\/10.1016\/j.ejso.2007.09.008.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"13830_CR76","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1007\/s13277-013-1358-y","volume":"35","author":"S Sugie","year":"2014","unstructured":"Sugie S, Tsukino H, Mukai S, et al. Cyclooxygenase 2 genotypes influence prostate cancer susceptibility in Japanese Men. Tumour Biol. 2014;35(3):2717\u201321. https:\/\/doi.org\/10.1007\/s13277-013-1358-y.","journal-title":"Tumour Biol"},{"issue":"1","key":"13830_CR77","first-page":"221","volume":"31","author":"HC Wu","year":"2011","unstructured":"Wu HC, Chang CH, Ke HL, et al. Association of cyclooxygenase 2 polymorphic genotypes with prostate cancer in taiwan. Anticancer Res. 2011;31(1):221\u20135.","journal-title":"Anticancer Res"},{"issue":"4","key":"13830_CR78","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/sj.bjc.6603874","volume":"97","author":"I Cheng","year":"2007","unstructured":"Cheng I, Liu X, Plummer SJ, Krumroy LM, Casey G, Witte JS. COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br J Cancer. 2007;97(4):557\u201361. https:\/\/doi.org\/10.1038\/sj.bjc.6603874.","journal-title":"Br J Cancer"},{"issue":"2","key":"13830_CR79","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1183\/09031936.05.00140104","volume":"26","author":"J Shi","year":"2005","unstructured":"Shi J, Misso NLA, Duffy DL, et al. Cyclooxygenase-1 gene polymorphisms in patients with different asthma phenotypes and atopy. Eur Respir J. 2005;26(2):249\u201356. https:\/\/doi.org\/10.1183\/09031936.05.00140104.","journal-title":"Eur Respir J"},{"issue":"55","key":"13830_CR80","doi-asserted-by":"publisher","first-page":"94358","DOI":"10.18632\/oncotarget.21719","volume":"8","author":"Y Du","year":"2017","unstructured":"Du Y, Weng XD, Wang L, et al. LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression. Oncotarget. 2017;8(55):94358\u201370. https:\/\/doi.org\/10.18632\/oncotarget.21719. Published 2017 Oct 10.","journal-title":"Oncotarget"},{"issue":"1","key":"13830_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrurol.2016.225","volume":"14","author":"V Rodriguez-Bravo","year":"2017","unstructured":"Rodriguez-Bravo V, Carceles-Cordon M, Hoshida Y, Cordon-Cardo C, Galsky MD, Domingo-Domenech J. The role of GATA2 in lethal prostate cancer aggressiveness. Nat Rev Urol. 2017;14(1):38\u201348. https:\/\/doi.org\/10.1038\/nrurol.2016.225.","journal-title":"Nat Rev Urol"},{"key":"13830_CR82","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.bbadis.2013.05.005","volume":"1832","author":"MR Pickard","year":"2013","unstructured":"Pickard MR, Mourtada-Maarabouni M, Williams GT. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta. 2013;1832:1613\u201323.","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"13830_CR83","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1158\/0008-5472.CAN-10-4513","volume":"71","author":"HH Mehta","year":"2011","unstructured":"Mehta HH, Gao Q, Galet C, et al. IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Res. 2011;71(15):5154\u201363. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4513.","journal-title":"Cancer Res"},{"issue":"2\u20133","key":"13830_CR84","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0167-4781(03)00074-5","volume":"1627","author":"A Teufel","year":"2003","unstructured":"Teufel A, Wong EA, Mukhopadhyay M, Malik N, Westphal H. FoxP4, a novel forkhead transcription factor. Biochim Biophys Acta. 2003;1627(2\u20133):147\u201352. https:\/\/doi.org\/10.1016\/s0167-4781(03)00074-5.","journal-title":"Biochim Biophys Acta"},{"issue":"7\u20138","key":"13830_CR85","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.cancergen.2013.06.001","volume":"206","author":"TI Kopp","year":"2013","unstructured":"Kopp TI, Friis S, Christensen J, Tj\u00f8nneland A, Vogel U. Polymorphisms in genes related to inflammation, NSAID use, and the risk of prostate cancer among Danish men. Cancer Genet. 2013;206(7\u20138):266\u201378. https:\/\/doi.org\/10.1016\/j.cancergen.2013.06.001.","journal-title":"Cancer Genet"},{"issue":"6","key":"13830_CR86","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.eururo.2013.12.058","volume":"65","author":"IM Shui","year":"2014","unstructured":"Shui IM, Lindstr\u00f6m S, Kibel AS, et al. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Eur Urol. 2014;65(6):1069\u201375. https:\/\/doi.org\/10.1016\/j.eururo.2013.12.058.","journal-title":"Eur Urol"},{"key":"13830_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2147\/OTT.S96294","volume":"9","author":"G Zhang","year":"2015","unstructured":"Zhang G, Zhu Y, Liu F, et al. Genetic variants in insulin-like growth factor binding protein-3 are associated with prostate cancer susceptibility in Eastern Chinese Han men. Onco Targets Ther. 2015;9:61\u20136. https:\/\/doi.org\/10.2147\/OTT.S96294. Published 2015 Dec 22.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"13830_CR88","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1093\/nar\/gku419","volume":"42","author":"S Bregenhorn","year":"2014","unstructured":"Bregenhorn S, Jiricny J. Biochemical characterization of a cancer-associated E109K missense variant of human exonuclease 1. Nucleic Acids Res. 2014;42(11):7096\u2013103. https:\/\/doi.org\/10.1093\/nar\/gku419.","journal-title":"Nucleic Acids Res"},{"issue":"6711","key":"13830_CR89","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/25141","volume":"396","author":"F Li","year":"1998","unstructured":"Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396(6711):580\u20134. https:\/\/doi.org\/10.1038\/25141.","journal-title":"Nature"},{"issue":"7","key":"13830_CR90","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/pros.21106","volume":"70","author":"GB Christensen","year":"2010","unstructured":"Christensen GB, Baffoe-Bonnie AB, George A, et al. Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate. 2010;70(7):735\u201344. https:\/\/doi.org\/10.1002\/pros.21106.","journal-title":"Prostate"},{"issue":"16","key":"13830_CR91","first-page":"6025","volume":"61","author":"DC Malins","year":"2001","unstructured":"Malins DC, Johnson PM, Wheeler TM, Barker EA, Polissar NL, Vinson MA. Age-related radical-induced DNA damage is linked to prostate cancer. Cancer Res. 2001;61(16):6025\u20138.","journal-title":"Cancer Res"},{"issue":"15","key":"13830_CR92","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1158\/0008-5472.CAN-08-0645","volume":"68","author":"Y Liu","year":"2008","unstructured":"Liu Y, Mo JQ, Hu Q, et al. Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer. Cancer Res. 2008;68(15):6396\u2013406. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0645.","journal-title":"Cancer Res"},{"issue":"5","key":"13830_CR93","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.canep.2013.05.007","volume":"37","author":"MS Mohd Suzairi","year":"2013","unstructured":"Mohd Suzairi MS, Tan SC, Ahmad Aizat AA, et al. The functional -94 insertion\/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer. Cancer Epidemiol. 2013;37(5):634\u20138. https:\/\/doi.org\/10.1016\/j.canep.2013.05.007.","journal-title":"Cancer Epidemiol"},{"issue":"12","key":"13830_CR94","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1089\/gtmb.2013.0267","volume":"17","author":"YF Zou","year":"2013","unstructured":"Zou YF, Tao JH, Ye QL, et al. Association of XPCA gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects. Genet Test Mol Biomarkers. 2013;17(12):926\u201331. https:\/\/doi.org\/10.1089\/gtmb.2013.0267.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"8","key":"13830_CR95","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.bcp.2004.01.006","volume":"67","author":"V Pavillard","year":"2004","unstructured":"Pavillard V, Drbal AA, Swaine DJ, Phillips RM, Double JA, Nicolaou A. Analysis of cell-cycle kinetics and sulfur amino acid metabolism in methionine-dependent tumor cell lines; the effect of homocysteine supplementation. Biochem Pharmacol. 2004;67(8):1587\u201399. https:\/\/doi.org\/10.1016\/j.bcp.2004.01.006.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"13830_CR96","doi-asserted-by":"publisher","first-page":"19191","DOI":"10.4238\/2015.December.29.29","volume":"14","author":"PL Chen","year":"2015","unstructured":"Chen PL, Li WT, Wang J, et al. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis. Genet Mol Res. 2015;14(4):19191\u2013202. https:\/\/doi.org\/10.4238\/2015.December.29.29. Published 2015 Dec 29.","journal-title":"Genet Mol Res"},{"issue":"8","key":"13830_CR97","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/jog.12989","volume":"42","author":"X Yu","year":"2016","unstructured":"Yu X, Zhou B, Zhang Z, et al. Insertion\/deletion polymorphism in IL1A 3\u2019-UTR is associated with susceptibility to endometrial cancer in Chinese Han women. J Obstet Gynaecol Res. 2016;42(8):983\u20139. https:\/\/doi.org\/10.1111\/jog.12989.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"13830_CR98","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/carcin\/bgaa088","volume":"42","author":"A Zhu","year":"2021","unstructured":"Zhu A, Hopkins KM, Friedman RA, Bernstock JD, Broustas CG, Lieberman HB. DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation. Carcinogenesis. 2021;42(2):220\u201331. https:\/\/doi.org\/10.1093\/carcin\/bgaa088.","journal-title":"Carcinogenesis"},{"issue":"10","key":"13830_CR99","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/sj.bjc.6604712","volume":"99","author":"ZJ Sun","year":"2008","unstructured":"Sun ZJ, Wang Y, Cai Z, Chen PP, Tong XJ, Xie D. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer. 2008;99(10):1656\u201367. https:\/\/doi.org\/10.1038\/sj.bjc.6604712.","journal-title":"Br J Cancer"},{"issue":"17\u201318","key":"13830_CR100","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32(17\u201318):1105\u201340. https:\/\/doi.org\/10.1101\/gad.315739.118.","journal-title":"Genes Dev"},{"issue":"8","key":"13830_CR101","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molmed.2005.06.007","volume":"11","author":"DA Guertin","year":"2005","unstructured":"Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med. 2005;11(8):353\u201361. https:\/\/doi.org\/10.1016\/j.molmed.2005.06.007.","journal-title":"Trends Mol Med"},{"issue":"6","key":"13830_CR102","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","volume":"17","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005;17(6):596\u2013603. https:\/\/doi.org\/10.1016\/j.ceb.2005.09.009.","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"13830_CR103","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006;124(3):471\u201384. https:\/\/doi.org\/10.1016\/j.cell.2006.01.016.","journal-title":"Cell"},{"issue":"4","key":"13830_CR104","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s12032-013-0693-6","volume":"30","author":"SC Tan","year":"2013","unstructured":"Tan SC, Suzairi MS, Aizat AA, et al. Gender-specific association of NFKBIA promoter polymorphisms with the risk of sporadic colorectal cancer. Med Oncol. 2013;30(4):693. https:\/\/doi.org\/10.1007\/s12032-013-0693-6.","journal-title":"Med Oncol"},{"issue":"4","key":"13830_CR105","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/pros.20098","volume":"61","author":"S Sakamoto","year":"2004","unstructured":"Sakamoto S, Yokoyama M, Aoki M, Suzuki K, Kakehi Y, Saito Y. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation. Prostate. 2004;61(4):305\u201317. https:\/\/doi.org\/10.1002\/pros.20098.","journal-title":"Prostate"},{"issue":"9","key":"13830_CR106","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s10552-012-0032-9","volume":"23","author":"A Gillio-Tos","year":"2012","unstructured":"Gillio-Tos A, Fiano V, Zugna D, et al. DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships. Cancer Causes Control. 2012;23(9):1549\u201355. https:\/\/doi.org\/10.1007\/s10552-012-0032-9.","journal-title":"Cancer Causes Control"},{"issue":"5","key":"13830_CR107","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1210\/en.2005-1270","volume":"147","author":"JV Silha","year":"2006","unstructured":"Silha JV, Sheppard PC, Mishra S, et al. Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms. Endocrinology. 2006;147(5):2112\u201321. https:\/\/doi.org\/10.1210\/en.2005-1270.","journal-title":"Endocrinology"},{"issue":"12","key":"13830_CR108","doi-asserted-by":"publisher","first-page":"e3858","DOI":"10.1371\/journal.pone.0003858","volume":"3","author":"M Pi","year":"2008","unstructured":"Pi M, Chen L, Huang MZ, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One. 2008;3(12):e3858. https:\/\/doi.org\/10.1371\/journal.pone.0003858.","journal-title":"PLoS One"},{"issue":"4","key":"13830_CR109","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/sj.ejhg.5201959","volume":"16","author":"I Cheng","year":"2008","unstructured":"Cheng I, Plummer SJ, Jorgenson E, et al. 8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet. 2008;16(4):496\u2013505. https:\/\/doi.org\/10.1038\/sj.ejhg.5201959.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"13830_CR110","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ng1808","volume":"38","author":"LT Amundadottir","year":"2006","unstructured":"Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet. 2006;38(6):652\u20138. https:\/\/doi.org\/10.1038\/ng1808.","journal-title":"Nat Genet"},{"issue":"4","key":"13830_CR111","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/sj.pcan.4501027","volume":"11","author":"S Hooker","year":"2008","unstructured":"Hooker S, Bonilla C, Akereyeni F, Ahaghotu C, Kittles RA. NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans. Prostate Cancer Prostatic Dis. 2008;11(4):349\u201356. https:\/\/doi.org\/10.1038\/sj.pcan.4501027.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"13830_CR112","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10552-009-9461-5","volume":"21","author":"I Agalliu","year":"2010","unstructured":"Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control. 2010;21(2):289\u2013300. https:\/\/doi.org\/10.1007\/s10552-009-9461-5.","journal-title":"Cancer Causes Control"},{"issue":"9","key":"13830_CR113","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1073\/pnas.1614265114","volume":"114","author":"F Panebianco","year":"2017","unstructured":"Panebianco F, Kelly LM, Liu P, et al. THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer. Proc Natl Acad Sci U S A. 2017;114(9):2307\u201312. https:\/\/doi.org\/10.1073\/pnas.1614265114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"52","key":"13830_CR114","doi-asserted-by":"publisher","first-page":"89620","DOI":"10.18632\/oncotarget.19210","volume":"8","author":"C Yajun","year":"2017","unstructured":"Yajun C, Chen Y, Xiaosa L, et al. Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation. Oncotarget. 2017;8(52):89620\u201330. https:\/\/doi.org\/10.18632\/oncotarget.19210. Published 2017 Jul 12.","journal-title":"Oncotarget"},{"issue":"5308","key":"13830_CR115","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1126\/science.275.5308.1943","volume":"275","author":"J Li","year":"1997","unstructured":"Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science. 1997;275(5308):1943\u20137. https:\/\/doi.org\/10.1126\/science.275.5308.1943.","journal-title":"Science"},{"issue":"10","key":"13830_CR116","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/ng.450","volume":"41","author":"RA Eeles","year":"2009","unstructured":"Eeles RA, Kote-Jarai Z, Al Olama AA, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet. 2009;41(10):1116\u201321. https:\/\/doi.org\/10.1038\/ng.450.","journal-title":"Nat Genet"},{"issue":"6","key":"13830_CR117","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.phrs.2007.04.015","volume":"55","author":"AP Fields","year":"2007","unstructured":"Fields AP, Regala RP. Protein kinase C iota: human oncogene, prognostic marker and therapeutic target. Pharmacol Res. 2007;55(6):487\u201397. https:\/\/doi.org\/10.1016\/j.phrs.2007.04.015.","journal-title":"Pharmacol Res"},{"issue":"2","key":"13830_CR118","doi-asserted-by":"publisher","first-page":"e16914","DOI":"10.1371\/journal.pone.0016914","volume":"6","author":"D Campa","year":"2011","unstructured":"Campa D, H\u00fcsing A, Stein A, et al. Genetic variability of the mTOR pathway and prostate cancer risk in the European prospective investigation on cancer (EPIC). PLoS One. 2011;6(2):e16914. https:\/\/doi.org\/10.1371\/journal.pone.0016914. Published 2011 Feb 23.","journal-title":"PLoS One"},{"issue":"1\u20132","key":"13830_CR119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mrfmmm.2009.09.009","volume":"690","author":"H Martin","year":"2010","unstructured":"Martin H. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components. Mutat Res. 2010;690(1\u20132):57\u201363. https:\/\/doi.org\/10.1016\/j.mrfmmm.2009.09.009. IF: 2.3 Q3.","journal-title":"Mutat Res"},{"issue":"2","key":"13830_CR120","first-page":"665","volume":"30","author":"J Klecka","year":"2010","unstructured":"Klecka J, Holubec L, Pesta M, et al. Differential display code 3 (DD3\/PCA3) in prostate cancer diagnosis. Anticancer Res. 2010;30(2):665\u201370.","journal-title":"Anticancer Res"},{"issue":"5","key":"13830_CR121","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrurol.2009.40","volume":"6","author":"D Hessels","year":"2009","unstructured":"Hessels D, Schalken JA. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol. 2009;6(5):255\u201361. https:\/\/doi.org\/10.1038\/nrurol.2009.40.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"13830_CR122","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000093805IF:3.5Q3","volume":"70","author":"JM Zmuda","year":"2006","unstructured":"Zmuda JM, Modugno F, Weissfeld JL, et al. Peroxisome proliferator-activated receptor-gamma polymorphism, body mass, and prostate cancer risk: evidence for gene-environment interaction. Oncology. 2006;70(3):185\u20139. https:\/\/doi.org\/10.1159\/000093805IF:3.5Q3.","journal-title":"Oncology"},{"issue":"5","key":"13830_CR123","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.juro.2010.06.098IF:6.6Q1","volume":"184","author":"SM Aubin","year":"2010","unstructured":"Aubin SM, Reid J, Sarno MJ, et al. PCA3 molecular urine test for predicting repeat prostate biopsy outcome in populations at risk: validation in the placebo arm of the dutasteride REDUCE trial. J Urol. 2010;184(5):1947\u201352. https:\/\/doi.org\/10.1016\/j.juro.2010.06.098IF:6.6Q1.","journal-title":"J Urol"},{"issue":"7092","key":"13830_CR124","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441(7092):431\u20136. https:\/\/doi.org\/10.1038\/nature04870.","journal-title":"Nature"},{"issue":"6","key":"13830_CR125","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1159\/000438577","volume":"37","author":"G Luo","year":"2015","unstructured":"Luo G, Wang M, Wu X, et al. Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cell Physiol Biochem. 2015;37(6):2209\u201320. https:\/\/doi.org\/10.1159\/000438577.","journal-title":"Cell Physiol Biochem"},{"issue":"21","key":"13830_CR126","first-page":"6830","volume":"50","author":"BS Carter","year":"1990","unstructured":"Carter BS, Epstein JI, Isaacs WB. ras gene mutations in human prostate cancer. Cancer Res. 1990;50(21):6830\u20132.","journal-title":"Cancer Res"},{"issue":"10","key":"13830_CR127","doi-asserted-by":"publisher","first-page":"e6280","DOI":"10.1097\/MD.0000000000006280","volume":"96","author":"C Chen","year":"2017","unstructured":"Chen C, Xin Z. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: a case-control study of Han Chinese men in Northeast China. Medicine (Baltimore). 2017;96(10):e6280. https:\/\/doi.org\/10.1097\/MD.0000000000006280.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"13830_CR128","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.juro.2016.08.103","volume":"197","author":"R Chen","year":"2017","unstructured":"Chen R, Sjoberg DD, Huang Y, et al. Prostate specific antigen and prostate cancer in Chinese men undergoing initial prostate biopsies compared with Western cohorts. J Urol. 2017;197(1):90\u20136. https:\/\/doi.org\/10.1016\/j.juro.2016.08.103.","journal-title":"J Urol"},{"issue":"5","key":"13830_CR129","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1089\/gtmb.2011.0160","volume":"16","author":"S Fontenete","year":"2012","unstructured":"Fontenete S, Nogueira A, Pina F, et al. Molecular study of the PCA3 gene: genotypic analysis of PCA3 polymorphism -845G>A and metastatic prostate cancer. Genet Test Mol Biomarkers. 2012;16(5):418\u201322. https:\/\/doi.org\/10.1089\/gtmb.2011.0160.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"13830_CR130","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1373\/clinchem.2013.211219","volume":"60","author":"C S\u00e4vblom","year":"2014","unstructured":"S\u00e4vblom C, Halld\u00e9n C, Cronin AM, et al. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men. Clin Chem. 2014;60(3):490\u20139. https:\/\/doi.org\/10.1373\/clinchem.2013.211219.","journal-title":"Clin Chem"},{"issue":"15","key":"13830_CR131","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/pros.21375","volume":"71","author":"SA Williams","year":"2011","unstructured":"Williams SA, Jelinek CA, Litvinov I, Cotter RJ, Isaacs JT, Denmeade SR. Enzymatically active prostate-specific antigen promotes growth of human prostate cancers. Prostate. 2011;71(15):1595\u2013607. https:\/\/doi.org\/10.1002\/pros.21375.","journal-title":"Prostate"},{"issue":"1","key":"13830_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pros.22532","volume":"73","author":"JT Bensen","year":"2013","unstructured":"Bensen JT, Xu Z, Smith GJ, Mohler JL, Fontham ET, Taylor JA. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. Prostate. 2013;73(1):11\u201322. https:\/\/doi.org\/10.1002\/pros.22532.","journal-title":"Prostate"},{"issue":"7","key":"13830_CR133","first-page":"2735","volume":"6","author":"Y Kitadai","year":"2000","unstructured":"Kitadai Y, Haruma K, Mukaida N, et al. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res. 2000;6(7):2735\u201340.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"13830_CR134","doi-asserted-by":"publisher","first-page":"e15011","DOI":"10.1371\/journal.pone.0015011","volume":"5","author":"HS de Vries","year":"2010","unstructured":"de Vries HS, te Morsche RH, van Oijen MG, Nagtegaal ID, Peters WH, de Jong DJ. The functional -765G\u2192C polymorphism of the COX-2 gene may reduce the risk of developing crohn\u2019s disease. PLoS One. 2010;5(11):e15011. https:\/\/doi.org\/10.1371\/journal.pone.0015011. Published 2010 Nov 24.","journal-title":"PLoS One"},{"issue":"3","key":"13830_CR135","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/1097-0045(20001101)45:3<225::aid-pros4>3.0.co;2-7","volume":"45","author":"F Kimura","year":"2000","unstructured":"Kimura F, Franke KH, Steinhoff C, et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate. 2000;45(3):225\u201331. https:\/\/doi.org\/10.1002\/1097-0045(20001101)45:3%3c225::aid-pros4%3e3.0.co;2-7.","journal-title":"Prostate"},{"issue":"9360","key":"13830_CR136","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(03)12713-4","volume":"361","author":"H Gr\u00f6nberg","year":"2003","unstructured":"Gr\u00f6nberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859\u201364. https:\/\/doi.org\/10.1016\/S0140-6736(03)12713-4.","journal-title":"Lancet"},{"issue":"6","key":"13830_CR137","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1083\/jcb.200505087","volume":"171","author":"HY Irie","year":"2005","unstructured":"Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol. 2005;171(6):1023\u201334. https:\/\/doi.org\/10.1083\/jcb.200505087.","journal-title":"J Cell Biol"},{"issue":"47","key":"13830_CR138","doi-asserted-by":"publisher","first-page":"36443","DOI":"10.1074\/jbc.M600788200","volume":"281","author":"GL Zhou","year":"2006","unstructured":"Zhou GL, Tucker DF, Bae SS, Bhatheja K, Birnbaum MJ, Field J. Opposing roles for Akt1 and Akt2 in Rac\/Pak signaling and cell migration. J Biol Chem. 2006;281(47):36443\u201353. https:\/\/doi.org\/10.1074\/jbc.M600788200.","journal-title":"J Biol Chem"},{"issue":"12","key":"13830_CR139","first-page":"3369","volume":"62","author":"SL McCarron","year":"2002","unstructured":"McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 2002;62(12):3369\u201372.","journal-title":"Cancer Res"},{"issue":"11","key":"13830_CR140","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/pros.23002","volume":"75","author":"W Tan","year":"2015","unstructured":"Tan W, Wang L, Ma Q, et al. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation. Prostate. 2015;75(11):1197\u2013205. https:\/\/doi.org\/10.1002\/pros.23002.","journal-title":"Prostate"},{"issue":"9","key":"13830_CR141","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.metabol.2011.01.005","volume":"60","author":"V Kaklamani","year":"2011","unstructured":"Kaklamani V, Yi N, Zhang K, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 2011;60(9):1234\u201343. https:\/\/doi.org\/10.1016\/j.metabol.2011.01.005.","journal-title":"Metabolism"},{"issue":"6894","key":"13830_CR142","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/418244a","volume":"418","author":"GJ Hannon","year":"2002","unstructured":"Hannon GJ. RNA interference. Nature. 2002;418(6894):244\u201351. https:\/\/doi.org\/10.1038\/418244a.","journal-title":"Nature"},{"issue":"12","key":"13830_CR143","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1158\/1055-9965.EPI-11-0434","volume":"20","author":"PK Dhillon","year":"2011","unstructured":"Dhillon PK, Penney KL, Schumacher F, et al. Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels, and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2618\u201327. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0434.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"13830_CR144","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1021\/bi027147i","volume":"42","author":"RH Silverman","year":"2003","unstructured":"Silverman RH. Implications for RNase L in prostate cancer biology. Biochemistry. 2003;42(7):1805\u201312. https:\/\/doi.org\/10.1021\/bi027147i.","journal-title":"Biochemistry"},{"key":"13830_CR145","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/1471-2148-8-226","volume":"8","author":"S Aftab","year":"2008","unstructured":"Aftab S, Semenec L, Chu JS, Chen N. Identification and characterization of novel human tissue-specific RFX transcription factors. BMC Evol Biol. 2008;8:226. https:\/\/doi.org\/10.1186\/1471-2148-8-226. Published 2008 Aug 1.","journal-title":"BMC Evol Biol"},{"issue":"10","key":"13830_CR146","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1158\/1055-9965.EPI-06-0361IF:3.8Q2","volume":"15","author":"I Cheng","year":"2006","unstructured":"Cheng I, Penney KL, Stram DO, et al. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1993\u20137. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0361IF:3.8Q2.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13830_CR147","doi-asserted-by":"publisher","unstructured":"Gurdasani D, Barroso I, Zeggini E, Sandhu MS. Genomics of disease risk in globally diverse populations [published correction appears in Nat Rev Genet. 2019 Sep;20(9):562. https:\/\/doi.org\/10.1038\/s41576-019-0153-z]. Nat Rev Genet. 2019;20(9):520\u2013535. https:\/\/doi.org\/10.1038\/s41576-019-0144-0.","DOI":"10.1038\/s41576-019-0153-z 10.1038\/s41576-019-0144-0"},{"issue":"7","key":"13830_CR148","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1089\/dna.2011.1600IF:3.1Q2","volume":"31","author":"J Liu","year":"2012","unstructured":"Liu J, Liu J, Wei M, et al. Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population. DNA Cell Biol. 2012;31(7):1296\u2013302. https:\/\/doi.org\/10.1089\/dna.2011.1600IF:3.1Q2.","journal-title":"DNA Cell Biol"},{"issue":"20","key":"13830_CR149","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1038\/onc.2010.605","volume":"30","author":"A Rojas","year":"2011","unstructured":"Rojas A, Liu G, Coleman I, et al. IL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR. Oncogene. 2011;30(20):2345\u201355. https:\/\/doi.org\/10.1038\/onc.2010.605.","journal-title":"Oncogene"},{"issue":"9","key":"13830_CR150","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.635","volume":"42","author":"R Takata","year":"2010","unstructured":"Takata R, Akamatsu S, Kubo M, et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet. 2010;42(9):751\u20134. https:\/\/doi.org\/10.1038\/ng.635.","journal-title":"Nat Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13830-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13830-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13830-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T14:13:37Z","timestamp":1743776017000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13830-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13830"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13830-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and did not involve human participants, human data, or human tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study does not include any person\u2019s data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"604"}}